echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > JAMA Oncol: Shock! Mothers with more than 30% less risk of ovarian cancer after more than 1 year of breastfeeding

    JAMA Oncol: Shock! Mothers with more than 30% less risk of ovarian cancer after more than 1 year of breastfeeding

    • Last Update: 2020-04-14
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    15 April 2020 /
    Biovalley BIOON/- An international study found that women who breastfed their babies had a nearly 25 percent lower risk of developing ovarian cancer studies also show that the longer women breastfeed, the greater the risk reduction senior Australian author Professor Penelope Webb, head of the Queensland Medical Research Institute's (QIMR) Berghofer Gynaecological Cancer Group, said breastfeeding could reduce the risk of all ovarian cancer, including the most deadly high-level plasma cancer Image source: http://cn.bing.com
    Professor Webb said: "Overall, breastfed women had a 24 per cent lower risk of developing ovarian cancer, and even those who breastfed for three months or less had an 18 per cent lower risk of developing ovarian cancer Mothers who breastfed their children for more than 12 months had a 34 percent lower risk of developing the disease Importantly, the benefits of breastfeeding last at least 30 years after women stop breastfeeding More than 1000 women died of ovarian cancer in Australia in 2019, accounting for nearly 5 per cent of cancer deaths last year, according to the Australian Institute of Health and Welfare only about 45 percent of women diagnosed with ovarian cancer can survive at least five years after diagnosis Said the international study was carried out by researchers from the Ovarian Cancer Society, who studied data from 9,973 ovarian cancer patients and 13,843 controlled women from around the world she said: "Previous studies have shown that breastfeeding can reduce the risk of ovarian cancer, but some studies have found no link between the two We therefore hope to clarify this relationship through a larger study The study shows a link between breastfeeding and reducing the incidence of ovarian cancer, and reinforces the World Health Organization's recommendation that mothers should only breastfeed for at least six months If they can continue to do so, they can continue to feed for more than two years by adding supplementary foods "
    studies have also shown that even short periods of breastfeeding can help reduce the risk of cancer " study builds on previous work at the institute, which found that breastfeeding was also associated with a lower risk of endometrial cancer Professor Webb says more research is needed to determine how breastfeeding affects cancer risk The findings were published in JAMA Oncology (BioValleyBioon.com) References: 1
    Breatfeeding linked to lower ovarian cancer .2 Ana Babic et al.
    Aociation And Ovarian Cancer Rik
    , JAMA Oncology (2020) DOI: 10.1001/jamaoncol.2020.0421
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.